Blog

November 15, 2016April 24, 2018

GIVENCHY ”WIRE”

GIVENCHY presents its new Fall/Winter 2016 eyewear collection. The collection channels unisex and oversized shapes, as well as materials mix. Iconic detailing, subtly incorporated in the various styles, conveys Givenchy’s unique identity and distinctive signature.

Models GV 7028/S and GV 0027 are a timeless shape combining an acetate frame with tailored metal wires. The metal staple has been over-emphasized on this squared model for a classic yet bold look. (Coming soon)

Distributed by Safilo: www.safilo.com

November 15, 2016April 24, 2018

Canadian Women ODs Honoured at American Academy

Pioneering women of vision were awarded the inaugural Theia Awards at the American Academy of Optometry annual meeting Nov. 10^th in Anaheim, California. Among the recipients are Drs. Barbara Pelletier, OD, and Laurie Capogna, OD.

The Theia awards, named after the Greek Goddess of Vision or Sight, is made to women on the basis of leadership, mentoring and innovation. Pelletier and Capogna are the authors of the EyeFoods series of books that bring knowledge of foods that promote eye health.

In total six women were Theia award winners, among more than 160 nominated.

Women in Optometry is published by Jobson Medial Inc., US partners of VuePoint IDS Inc.

Web address: https://www.reviewofoptometry.com/wo/surveys-and-news/article/nominations-open-for-the-2016-women-in-optometry-theia-awards-of-excellence/

November 14, 2016April 24, 2018

Novartis on Alcon: All Options are Open

Reuters reported yesterday, that Swiss parent of Alcon, drugmaker Novartis is considering the sale of its eye care unit Alcon. The source is an interview with the Swiss weekly SonntagsZeitung.

Novartis Chief Executive Joe Jimenez said that the turnaround at Alcon will take longer than expected, citing October unit sales to be flat to declining.

Chairman Joerg Reihhard indicated the division has not developed as expected, “In the long run, the questions arises as to whether we are the best owner for Alcon.”

Infoclip.ca has reported that Novartis was considering selling Alcon’s contact lens care business December 2, 2015 and that Alcon had replaced their CEO and restructured after poor earnings report in January 2016.

Source: http://www.reuters.com/article/us-novartis-divestiture-alcon-idUSKBN1380EZ

November 11, 2016April 24, 2018

Urban Romantic

This Mexx model (5354) is a vintage inspired, aesthetically balanced style made from acetate. With its slightly curved top line and delicate endpiecesand temples, this model is at once stylish and feminine. The embossed, geometric temple design fits in perfectly with the current urban romantic trend. A super comfortable style for the young or young at heart.

Distributed by Lanctôt: www.rlanctot.com

November 11, 2016April 24, 2018

Canadian to Receive CNIB Chanchlani Global Vision Research Award

CNIB Alberta announces that Dr. Robert Molday has been selected as the recipient of the CNIB Chanchlani Global Vision Research Award.

The first Canadian to receive this prestigious award, Dr. Molday (pictured, right) is a faculty member at the University of British Columbia where he currently holds positions as Professor of Biochemistry & Molecular Biology and Ophthalmology & Visual Sciences and is the founding Director of the Centre for Macular Research.

The CNIB Chanchlani Global Vision Research Award was established in 2011 to support the best research in the field of vision science and rehabilitation, worldwide, with the goal of encouraging world researchers in the area of vision science and vision rehabilitation. The award is given to vision scientists who have made a major original contribution to these fields.

Dr. Molday is being recognized for his contributions to the field of vision and inherited retinal degenerative diseases. His innovative experimental approaches and creative thinking, together with the extensive range of his studies, have led to scientific breakthroughs that have had a major impact on our understanding of photoreceptor cell structure and function, as well as the molecular and cellular basis of inherited retinal degenerative diseases. His studies have served as a basis for the development of new therapeutic approaches for the treatment retinal degenerative disorders, most notably Stargardt’s Syndrome.

Click HERE to read the full press release.